GlassScriptPhysician profile
Jose S Cisneros
NPI 1487728127
$1,008.20
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $54.08 · 2021: $56.89 · 2022: $353 · 2023: $65.61 · 2024: $41.91 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $334.96 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $168.60 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $126.85 | 2019-2022 | |
| Abbvie INC. | $94.96 | 2019-2023 | Lo Loestrin Fe |
| Lilly USA, LLC | $74.95 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $66.28 | 2019-2021 | |
| Mission Pharmacal Company | $61.84 | 2019 | |
| Medtronic, INC. | $29.99 | 2024 | Mazor X System |
| Allergan, INC. | $19.32 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.53 | 2019 | |
| Organon LLC | $11.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Cisneros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.